(800)525-7111 Free Consultation

Zantac Causes Cancer: True or False?

Riddle Brantley LLP   |  April 3, 2020   |  

Does Zantac cause cancer? Alarming new evidence from the FDA and independent labs suggests that it might. Here’s what we know so far about whether Zantac causes cancer:

Zantac and Cancer: Is There a Link?

In late 2019, two independent labs separately confirmed that they had detected elevated levels of NDMA in Zantac and other drugs containing ranitidine (generic for Zantac). The FDA confirmed these findings shortly afterward. NDMA Is a naturally occurring chemical that is known to be carcinogenic, meaning it can cause cancer.

Whether or not Zantac causes cancer, therefore, may depend on the amount of NDMA contamination present.

Zantac Causes Cancer - Evidence Suggests It May - Riddle & BrantleyIn issuing several urgent warnings about Zantac cancer risk, the FDA advised that Zantac contains “unacceptable” levels of NDMA, indicating that the amount of NDMA detected in Zantac may cause cancer.

Nevertheless, it is important to note that tests have not established a direct causal link between Zantac and cancer. Yet the evidence strongly suggests that, potentially, NDMA-contaminated Zantac causes cancer.

These cancers may include:

>>For more information on potential Zantac cancer risks and related lawsuits, please visit our Zantac cancer FAQs page

Our attorneys are actively investigating these claims.

Have you or a loved one been diagnosed with cancer after taking Zantac?

Zantac and Cancer Claims - Zantac Lawsuit Attorneys - Riddle & BrantleyIf you or a loved one has been diagnosed with one of the following cancers after taking brand-name Zantac, you may be entitled to financial compensation. Please call 1-800-525-7111 today to speak with an experienced attorney about a potential Zantac lawsuit.

You may qualify for a Zantac lawsuit if you meet the following criteria:

  • Used brand-name Zantac only
  • Suffered from at least one of the following cancers:
    • Bladder cancer
    • Liver cancer
    • Stomach cancer
    • Esophageal cancer
    • Pancreatic cancer
    • Lung cancer
    • Colorectal cancer
    • Prostate cancer
  • Must have used brand-name Zantac after October 1984
  • Must have used brand-name Zantac for a minimum of one year
  • Must have used brand-name Zantac once per week for a minimum of six months
  • Must have been diagnosed with a qualifying cancer within 20 years of last dose
  • Must not have been a smoker in the past 20 years if diagnosed with lung cancer
  • Must be 64 years of age or younger at the time of diagnosis if diagnosed with prostate cancer

Certain other criteria may apply. For a FREE, no-obligation consultation with an experienced Zantac lawsuit attorney, please call 1-800-525-7111.

IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac OR “mixed” use of brand-name Zantac and generic equivalents.

Our Experience

Since 1985, our attorneys have been fighting for those injured due to the negligence of others. We believe Justice Counts and are committed to holding potentially negligent drug companies accountable for their products and actions.

For a FREE, no-obligation consultation with the experienced dangerous drug lawyers at Riddle & Brantley about a potential Zantac cancer lawsuit, please call 1-800-525-7111 or complete the short form below.

“They turned a heartbreaking situation completely around.”

Tonya Taylor, Riddle & Brantley client 

Evidence suggests that, potentially, NDMA-contaminated Zantac causes cancer and our firm is actively investigating these claims.

If you or a loved one has suffered cancer due to a potentially dangerous drug like Zantac, you deserve justice and we would love to help however we can.

Please call 1-800-525-7111 today for a FREE, no-obligation case review today.

Justice Counts.

 


***Disclaimer: No settlement agreement has been reached in any litigation regarding ranitidine (ZANTAC®), including in the Multidistrict Litigation in the United States District Court for the Southern District of Florida (case no. 20-MD-2924).